Patent details

Basic Information

Publication number:

EP2281037

PCT Application Number:

PCT/US/2009/002248

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP097308522

PCT Publication Number:

WO/2009/126307

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

FACTOR VII POLYPEPTIDES THAT ARE MODIFIED AND USES THEREOF

French Title of Invention:

POLYPEPTIDES FACTEUR VII MODIFIÉS ET LEURS UTILISATIONS

German Title of Invention:

FAKTOR-VII-POLYPEPTIDE MIT MODIFIKATIONEN UND VERWENDUNGEN DAVON

SPC Number:

Dates

Filing date:

10/04/2009

Grant date:

11/11/2015

EP Publication Date:

11/11/2015

PCT Publication Date:

15/10/2009

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

09/02/2011

EP B1 Publication Date:

11/11/2015

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

10/04/2022

Expiration date:

10/04/2029

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

10/04/2009

 

 

Name:

Catalyst Biosciences Inc.

Address:

260 Littlefield Avenue, South San Francisco, CA 94080, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

18/11/2015

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

THANOS Christopher

Address:

United States (US)

2

Name:

MADISON Edwin, L.

Address:

United States (US)

Priority

Priority Number:

124021 P

Priority Date:

11/04/2008

Priority Country:

United States (US)

Classification

Main IPC Class:

C12N 9/64;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

20/04/2021

Last Annual Fee Paid Number:

13

Last Annual Fee Paid Amount:

180 Euro

Payer:

DENNEMEYER & CO

Filing date	Document type	Number of pages